$1.23 Billion is the total value of Slate Path Capital LP's 21 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 50.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
SNAP | Buy | SNAP INCcl a | $243,432,000 | +237.1% | 22,090,000 | +68.6% | 19.72% | +142.3% |
CHTR | Buy | CHARTER COMMUNICATIONS INC Ncl a | $159,579,000 | +56.0% | 460,000 | +28.1% | 12.93% | +12.1% |
GOLD | Buy | BARRICK GOLD CORPORATION | $157,871,000 | +16.9% | 11,515,000 | +15.4% | 12.79% | -16.0% |
NYT | Buy | NEW YORK TIMES COcl a | $124,502,000 | +68.0% | 3,790,000 | +14.0% | 10.09% | +20.8% |
GDX | Sell | VANECK VECTORS ETF TRgold miners etf | $107,952,000 | -19.6% | 4,815,000 | -24.4% | 8.75% | -42.2% |
GE | Buy | GENERAL ELECTRIC CO | $103,397,000 | +162.2% | 10,350,000 | +98.7% | 8.38% | +88.5% |
ALLY | ALLY FINL INC | $63,502,000 | +21.3% | 2,310,000 | 0.0% | 5.14% | -12.8% | |
KEX | New | KIRBY CORP | $61,966,000 | – | 825,000 | +100.0% | 5.02% | – |
MDCO | Buy | MEDICINES CO | $60,652,000 | +52.7% | 2,170,000 | +4.6% | 4.91% | +9.8% |
ALNY | ALNYLAM PHARMACEUTICALS INC | $44,856,000 | +28.2% | 480,000 | 0.0% | 3.63% | -7.9% | |
Z | New | ZILLOW GROUP INCcl c cap stk | $34,740,000 | – | 1,000,000 | +100.0% | 2.82% | – |
PAAS | Buy | PAN AMERICAN SILVER CORP | $27,295,000 | +595.1% | 2,060,000 | +665.8% | 2.21% | +399.1% |
GPRE | New | GREEN PLAINS INC | $10,175,000 | – | 610,000 | +100.0% | 0.82% | – |
ARNA | New | ARENA PHARMACEUTICALS INC | $9,638,000 | – | 215,000 | +100.0% | 0.78% | – |
ZG | Buy | ZILLOW GROUP INCcl a | $6,327,000 | +134.1% | 185,000 | +115.1% | 0.51% | +68.2% |
WPM | WHEATON PRECIOUS METALS CORP | $4,716,000 | +22.0% | 198,000 | 0.0% | 0.38% | -12.4% | |
TDW | TIDEWATER INC NEW | $4,406,000 | +21.2% | 190,000 | 0.0% | 0.36% | -12.9% | |
SDRLF | SEADRILL LTD | $3,241,000 | -14.8% | 390,000 | 0.0% | 0.26% | -38.7% | |
SNAP | SNAP INCcall | $2,975,000 | +99.9% | 270,000 | 0.0% | 0.24% | +43.5% | |
BMA | New | BANCO MACRO SAspon adr b | $1,968,000 | – | 43,000 | +100.0% | 0.16% | – |
AG | FIRST MAJESTIC SILVER CORP | $1,119,000 | +11.8% | 170,000 | 0.0% | 0.09% | -19.5% | |
XME | Exit | SPDR SERIES TRUSTs&p metals mng | $0 | – | -120,000 | -100.0% | -0.35% | – |
EEM | Exit | ISHARES TRmsci emg mkt etf | $0 | – | -110,000 | -100.0% | -0.48% | – |
GG | Exit | GOLDCORP INC NEW | $0 | – | -745,000 | -100.0% | -0.82% | – |
QQQ | Exit | INVESCO QQQ TRput | $0 | – | -65,000 | -100.0% | -1.13% | – |
CF | Exit | CF INDS HLDGS INC | $0 | – | -1,565,000 | -100.0% | -7.68% | – |
MOS | Exit | MOSAIC CO NEW | $0 | – | -3,065,000 | -100.0% | -10.09% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-05-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
CHARTER COMMUNICATIONS INC N | 30 | Q3 2023 | 15.2% |
ALNYLAM PHARMACEUTICALS INC | 30 | Q3 2020 | 8.9% |
UNITED STATES STL CORP NEW | 24 | Q3 2023 | 11.4% |
NEW YORK TIMES CO | 23 | Q3 2023 | 10.9% |
VANECK VECTORS ETF TR | 21 | Q3 2023 | 19.5% |
PAN AMERN SILVER CORP | 21 | Q3 2023 | 7.6% |
CUE BIOPHARMA INC | 17 | Q3 2023 | 1.3% |
BARRICK GOLD CORPORATION | 16 | Q4 2020 | 15.7% |
MOSAIC CO NEW | 15 | Q4 2021 | 16.8% |
MEDICINES CO | 15 | Q4 2019 | 12.2% |
View Slate Path Capital LP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Cue Biopharma, Inc. | February 14, 2023 | 2,402,455 | 5.6% |
Stitch Fix, Inc. | February 14, 2023 | ? | ? |
Cyclerion Therapeutics, Inc. | January 13, 2023 | 7,157,601 | 16.5% |
Zimmer Energy Transition Acquisition Corp. | February 14, 2022 | 2,000,000 | 5.8% |
5:01 Acquisition Corp. | February 11, 2022 | 500,000 | 5.8% |
Hippo Holdings Inc. | February 11, 2022 | 350,000 | 0.1% |
Warner Music Group Corp. | February 11, 2022 | 3,134,779 | 2.6% |
Reinvent Technology Partners Z | February 16, 2021 | 1,750,000 | 7.6% |
View Slate Path Capital LP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
SC 13G/A | 2024-01-22 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
SC 13G/A | 2023-02-14 |
SC 13G | 2023-02-14 |
13F-HR | 2023-02-14 |
SC 13G | 2023-01-13 |
SC 13G | 2022-11-18 |
View Slate Path Capital LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.